QuadMedicine, Inc. (KOSDAQ:464490)
South Korea · Delayed Price · Currency is KRW
13,170
-1,130 (-7.90%)
At close: Apr 2, 2026
QuadMedicine Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
|---|
| 26,507 | 10,263 | 4,449 |
| 1,010 | - | - |
Cash & Short-Term Investments | 27,517 | 10,263 | 4,449 |
| 168.12% | 130.69% | - |
| 1,803 | 1,100 | 18.41 |
| 393.82 | 3.22 | 0.23 |
| 2,974 | 1,103 | 18.64 |
| 8.05 | 86.89 | 512.18 |
| 540.93 | 232.97 | 69.03 |
| 31,040 | 11,686 | 5,049 |
Property, Plant & Equipment | 19,299 | 19,752 | 19,549 |
| - | 10 | - |
| 597.95 | 493.21 | 364.21 |
Long-Term Accounts Receivable | -0 | -0 | -0 |
| 242.17 | 157.35 | 257.19 |
|
| 500 | 500 | - |
Current Portion of Long-Term Debt | 5,900 | 99.6 | - |
Current Portion of Leases | 283.22 | 206.35 | 295.71 |
Other Current Liabilities | 4,138 | 5,524 | 3,616 |
Total Current Liabilities | 10,821 | 6,330 | 3,912 |
| 551 | 6,451 | 5,800 |
| 249.76 | 106.84 | 327.7 |
Other Long-Term Liabilities | 8,759 | 7,611 | 6,217 |
|
| 5,671 | 4,676 | 4,358 |
Additional Paid-In Capital | 71,338 | 45,483 | 38,472 |
| -48,619 | -41,688 | -36,720 |
Comprehensive Income & Other | 2,409 | 3,128 | 2,853 |
|
Total Liabilities & Equity | 51,179 | 32,098 | 25,219 |
| 7,484 | 7,363 | 6,423 |
| 20,033 | 2,899 | -1,975 |
| 590.96% | - | - |
| 2086.82 | 332.64 | -228.65 |
Filing Date Shares Outstanding | 10.1 | 9.35 | 8.74 |
Total Common Shares Outstanding | 10.1 | 9.35 | 8.74 |
| 20,219 | 5,356 | 1,137 |
| 3049.49 | 1240.40 | 1025.97 |
| 30,201 | 11,107 | 8,599 |
Tangible Book Value Per Share | 2990.28 | 1187.66 | 984.28 |
| 2,187 | 2,187 | 1,951 |
| 9,683 | 9,683 | 8,572 |
| 10,997 | 9,130 | 7,681 |
| 317.24 | 171.69 | 555.41 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.